Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 28

Page
per page
  1. Bicalutamide
    A5065 Bicalutamide
     1 Citation
    Target: Androgen Receptors
    Summary: Androgen receptor antagonist
      ≥42.89 mg/mL
  2. ADL5859 HCl
    A2986 ADL5859 HCl
    Summary: δ-opioid receptor agonist,selective
      ≥21.45 mg/mL
  3. Andarine
    A2150 Andarine
    Target: Androgen Receptors
    Summary: Androgen receptor agonist
      ≥21 mg/mL
  4. ARN-509
    A8364 ARN-509
     2 Citation
    Target: Androgen Receptor
    Summary: Androgen receptor inhibitor
      ≥23.85 mg/mL
  5. JTC-801
    A8456 JTC-801
    Target: NOP Receptors
    Summary: KOR-3 (NOP) receptor antagonist
      ≥22.4 mg/mL
  6. TOK-001
    A8623 TOK-001
    Target: Androgen Receptors|Cytochrome P450 (CYP450)
    Summary: CYP17 inhibitor and androgen receptor (AR) antagonist
      insoluble in H2O; ≥12.4 mg/mL
  7. XCT790
    B3238 XCT790
    Target: Estrogen and Related Receptors
    Summary: ERRα agonist
      insoluble in H2O; ≥14.9 mg/mL
  8. Raloxifene HCl
    B1515 Raloxifene HCl
    Target: Estrogen and Related Receptors
    Summary: Estrogen receptor (ER)
      ≥22.35 mg/mL
  9. JDTic
    A3517 JDTic
    Summary: Opioid antagonist
      Soluble in DMSO
  10. JDTic 2HCl
    A3518 JDTic 2HCl
    Summary: κ-opioid receptor antagonist
      Soluble in DMSO

Items 1-10 of 28

Page
per page